1. EMA requires restricted use while reviewing alemtuzumab

   News item 27 April 2019 Pages: 1 - 1

2. EMA review of high-strength estradiol vaginal creams

   News item 27 April 2019 Pages: 2 - 2

3. FDA orders labelling change for flibanserin re alcohol interaction

   News item 27 April 2019 Pages: 3 - 3

4. Medicinal cannabis adverse reactions in Denmark

   News item 27 April 2019 Pages: 4 - 4

5. Non-melanoma skin cancers with hydrochlorothiazide

   News item 27 April 2019 Pages: 5 - 5

6. TGA investigates risk of aortic aneurysm, dissection with FQs

   News item 27 April 2019 Pages: 6 - 6

7. US FDA approves first generic naloxone spray

   News item 27 April 2019 Pages: 7 - 7

8. Clinical outcomes with polypharmacy in RA

   Clinical study 27 April 2019 Pages: 8 - 8

9. HIV pre-exposure prophylaxis and sexually transmitted infections

   Clinical study 27 April 2019 Pages: 9 - 9

10. Hyponatraemia/SIADH with antidepressant drugs

    Clinical study 27 April 2019 Pages: 10 - 10

11. Pneumonia with antiepileptic drugs in AD patients

    Clinical study 27 April 2019 Pages: 11 - 11

12. Subclinical coronary artery disease with antiretrovirals

    Clinical study 27 April 2019 Pages: 12 - 12

13. Abatacept

    Case report 27 April 2019 Pages: 13 - 13

14. Abiraterone/enzalutamide

    Case report 27 April 2019 Pages: 14 - 14

15. Acetazolamide/fampridine

    Case report 27 April 2019 Pages: 15 - 15

16. Adalimumab

    Case report 27 April 2019 Pages: 16 - 16

17. Adalimumab

    Case report 27 April 2019 Pages: 17 - 17

18. Adalimumab/etanercept/naproxen

    Case report 27 April 2019 Pages: 18 - 18

19. Adefovir dipivoxil/tenofovir

    Case report 27 April 2019 Pages: 19 - 19

20. Adefovir-dipivoxil/lamivudine

    Case report 27 April 2019 Pages: 20 - 20

21. Adefovir/lamivudine

    Case report 27 April 2019 Pages: 21 - 21

22. Alemtuzumab

    Case report 27 April 2019 Pages: 22 - 22

23. Alemtuzumab

    Case report 27 April 2019 Pages: 23 - 23

24. Alendronic acid/leflunomide

    Case report 27 April 2019 Pages: 24 - 24

25. Alteplase

    Case report 27 April 2019 Pages: 25 - 25

26. Amiodarone

    Case report 27 April 2019 Pages: 26 - 26

27. Amiodarone

    Case report 27 April 2019 Pages: 27 - 27

28. Amlodipine

    Case report 27 April 2019 Pages: 28 - 28

29. Amlodipine

    Case report 27 April 2019 Pages: 29 - 29

30. Amphotericin/anticoagulants

    Case report 27 April 2019 Pages: 30 - 30

31. Ampicillin/bevacizumab/gentamicin

    Case report 27 April 2019 Pages: 31 - 31

32. Anakinra

    Case report 27 April 2019 Pages: 32 - 32

33. Anastrozole

    Case report 27 April 2019 Pages: 33 - 33

34. Anthracyclines/cytarabine

    Case report 27 April 2019 Pages: 34 - 34

35. Anti-inflammatories/methotrexate/steroid

    Case report 27 April 2019 Pages: 35 - 35

36. Antibacterials/antituberculars

    Case report 27 April 2019 Pages: 36 - 36

37. Antidepressants/GABA receptor agonists overdose

    Case report 27 April 2019 Pages: 37 - 37

38. Antineoplastics

    Case report 27 April 2019 Pages: 38 - 38

39. Antineoplastics

    Case report 27 April 2019 Pages: 39 - 39

40. Antineoplastics

    Case report 27 April 2019 Pages: 40 - 40

41. Antineoplastics

    Case report 27 April 2019 Pages: 41 - 41

42. Antineoplastics/folinic acid

    Case report 27 April 2019 Pages: 42 - 42

43. Antineoplastics/folinic-acid

    Case report 27 April 2019 Pages: 43 - 43

44. Antiparkinsonian drugs withdrawal

    Case report 27 April 2019 Pages: 44 - 44

45. Antipsychotic drugs

    Case report 27 April 2019 Pages: 45 - 45

46. Antituberculars

    Case report 27 April 2019 Pages: 46 - 46

47. Antivirals

    Case report 27 April 2019 Pages: 47 - 47

48. Apixaban/heparin

    Case report 27 April 2019 Pages: 48 - 48

49. Apixaban/thalidomide

    Case report 27 April 2019 Pages: 49 - 49

50. Apremilast/nivolumab

    Case report 27 April 2019 Pages: 50 - 50